1IMR
MOLECULAR STRUCTURE OF THE HALOGENATED ANTI-CANCER DRUG IODODOXORUBICIN COMPLEXED WITH D(TGTACA) AND D(CGATCG)
Functional Information from PDB Data
| site_id | 1 |
| Number of Residues | |
| Details |
| Chain | Residue |
| site_id | AC1 |
| Number of Residues | 12 |
| Details | BINDING SITE FOR RESIDUE DM7 A 7 |
| Chain | Residue |
| A | DT1 |
| A | HOH25 |
| A | HOH28 |
| A | HOH45 |
| A | DG2 |
| A | DT3 |
| A | DA4 |
| A | DC5 |
| A | DA6 |
| A | HOH8 |
| A | HOH9 |
| A | HOH23 |
